Øystein Rekdal (CEO in Lytix Biopharma) has accepted an invitation to give an oral presentation at Esmo Immuno-Oncology Congress in Geneva, Switzerland.
Under the session name ‘New vaccine technologies and administration modalities’, Øystein will give his presentation ‘Addressing heterogeneity: A hot topic’.
Location: Room C, Geneva Palexpo, Geneva, Switzerland
Time: 16:00 - 17:30
Read more about the conference here